avicorelogo.png
First HealthTab™ Testing Success in Shoppers Drug Mart® Pilot Rollout
June 29, 2021 07:00 ET | Avricore Health Inc.
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces it has successfully launched HealthTab™ in the first of 11...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Receives $3 Million NIH Commercialization Readiness Pilot Grant Award for Novel Amyloid Beta Retinal Tracer in Cerebral Amyloid Angiopathy
June 28, 2021 07:00 ET | Amydis, Inc.
SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
avicorelogo.png
Avricore Health Corporate Update Summer 2021
June 09, 2021 08:00 ET | Avricore Health Inc.
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s successes in...
avicorelogo.png
Avricore Health Signs Master Agreement to Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
June 03, 2021 09:30 ET | Avricore Health Inc.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have...
avicorelogo.png
Avricore Health’s HealthTab™ Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
May 31, 2021 08:00 ET | Avricore Health Inc.
VANCOUVER, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier...
LOGO-01.png
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
May 19, 2021 05:06 ET | Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
Amydis_Logo_Horiz_RGB@2x.png
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of a First-in-Class Retinal Tracer for the Diagnosis of Alpha-synucleinopathies
April 26, 2021 07:00 ET | Amydis, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer biotechnology company with a broad portfolio of diagnostic candidates for detection of neurodegenerative diseases...
Analytical Accuracy
Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
April 13, 2021 03:39 ET | Burning Rock Biotech Limited
GUANGZHOU, China, April 13, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that its liquid biopsy assay has achieved strong...
avicorelogo.png
Avricore Health Announces Return of HealthTab™ Founder to Communications and Marketing Role
March 26, 2021 08:00 ET | Avricore Health Inc.
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR, OTC: AVCRF) (the "Company" or “AVCR”) is pleased to announce the return of HealthTab Co-Founder,...
avicorelogo.png
Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening
March 18, 2021 08:30 ET | Avricore Health Inc.
The companies agree to offer HealthTab™ and COVID-19 rapid-antigen tests at resort locations, delivering fast and accurate results for travellers returning to the US. VANCOUVER, British Columbia,...